GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » HeartSciences Inc (NAS:HSCS) » Definitions » FCF Yield %

HSCS (HeartSciences) FCF Yield % : -259.33 (As of Apr. 07, 2025)


View and export this data going back to 2022. Start your Free Trial

What is HeartSciences FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, HeartSciences's Trailing 12-Month Free Cash Flow is $-7.49 Mil, and Market Cap is $2.89 Mil. Therefore, HeartSciences's FCF Yield % for today is -259.33%.

The historical rank and industry rank for HeartSciences's FCF Yield % or its related term are showing as below:

HSCS' s FCF Yield % Range Over the Past 10 Years
Min: -404.28   Med: -98.78   Max: -18.34
Current: -259.33


During the past 5 years, the highest FCF Yield % of HeartSciences was -18.34%. The lowest was -404.28%. And the median was -98.78%.

HSCS's FCF Yield % is ranked worse than
97.01% of 871 companies
in the Medical Devices & Instruments industry
Industry Median: -2.01 vs HSCS: -259.33

HeartSciences's FCF Margin % for the quarter that ended in Jan. 2025 was 0.00%.


HeartSciences FCF Yield % Historical Data

The historical data trend for HeartSciences's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HeartSciences FCF Yield % Chart

HeartSciences Annual Data
Trend Apr20 Apr21 Apr22 Apr23 Apr24
FCF Yield %
- - - -64.62 -99.03

HeartSciences Quarterly Data
Apr20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -90.27 -105.25 -231.64 -314.30 -196.46

Competitive Comparison of HeartSciences's FCF Yield %

For the Medical Devices subindustry, HeartSciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HeartSciences's FCF Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, HeartSciences's FCF Yield % distribution charts can be found below:

* The bar in red indicates where HeartSciences's FCF Yield % falls into.


;
;

HeartSciences FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

HeartSciences's FCF Yield % for the fiscal year that ended in Apr. 2024 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-6.195 / 6.25548
=-99.03%

HeartSciences's annualized FCF Yield % for the quarter that ended in Jan. 2025 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-1.636 * 4 / 3.3309864
=-196.46%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HeartSciences FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


HeartSciences FCF Yield % Related Terms

Thank you for viewing the detailed overview of HeartSciences's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


HeartSciences Business Description

Traded in Other Exchanges
N/A
Address
550 Reserve Street, Suite 360, Southlake, TX, USA, 76092
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
Executives
David R. Wells director 2801 OCEAN PARK BLVD., SUITE 339, SANTA MONICA CA 90405
Bruce Bent director 750 BONHAM PARKWAY, LANTANA TX 76226
Mark T Hilz director, officer: See Remarks 3301 DAKOTA DRIVE, NORTHLAKE TX 76226
Patrick Kanouff director 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Brian Szymczak director 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Danielle Watson officer: See Remarks 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Andrew Simpson director, officer: See Remarks 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092